NO20070157L - Substituerte diketopiperaziner som oksytocinantagonister - Google Patents

Substituerte diketopiperaziner som oksytocinantagonister

Info

Publication number
NO20070157L
NO20070157L NO20070157A NO20070157A NO20070157L NO 20070157 L NO20070157 L NO 20070157L NO 20070157 A NO20070157 A NO 20070157A NO 20070157 A NO20070157 A NO 20070157A NO 20070157 L NO20070157 L NO 20070157L
Authority
NO
Norway
Prior art keywords
oxytocin antagonists
methyl
substituted diketopiperazines
diketopiperazines
substituted
Prior art date
Application number
NO20070157A
Other languages
English (en)
Norwegian (no)
Inventor
Alan David Borthwick
Steven Leslie Sollis
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20070157L publication Critical patent/NO20070157L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20070157A 2004-06-23 2007-01-09 Substituerte diketopiperaziner som oksytocinantagonister NO20070157L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0414092.7A GB0414092D0 (en) 2004-06-23 2004-06-23 Novel compounds
PCT/EP2005/006761 WO2006000400A1 (en) 2004-06-23 2005-06-21 Substituted diketopiperazines as oxytocin antagonists

Publications (1)

Publication Number Publication Date
NO20070157L true NO20070157L (no) 2007-01-23

Family

ID=32800052

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070157A NO20070157L (no) 2004-06-23 2007-01-09 Substituerte diketopiperaziner som oksytocinantagonister

Country Status (18)

Country Link
US (1) US20070208031A1 (pt)
EP (1) EP1758893A1 (pt)
JP (1) JP2008503535A (pt)
CN (1) CN1989130A (pt)
AR (1) AR049651A1 (pt)
AU (1) AU2005256471A1 (pt)
BR (1) BRPI0512359A (pt)
CA (1) CA2571529A1 (pt)
GB (1) GB0414092D0 (pt)
IL (1) IL179912A0 (pt)
MA (1) MA28698B1 (pt)
MX (1) MXPA06014544A (pt)
NO (1) NO20070157L (pt)
PE (1) PE20060533A1 (pt)
RU (1) RU2007102272A (pt)
TW (1) TW200616635A (pt)
WO (1) WO2006000400A1 (pt)
ZA (1) ZA200610121B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2641806B1 (fr) * 1989-01-16 1992-05-07 Diffusion Rech Tech Financ Procede de stabilisation d'une aire de terrain meuble
GB0130677D0 (en) * 2001-12-21 2002-02-06 Glaxo Group Ltd Medicaments and novel compounds
GB0314738D0 (en) 2003-06-24 2003-07-30 Glaxo Group Ltd Novel compounds
GB0414100D0 (en) * 2004-06-23 2004-07-28 Glaxo Group Ltd Novel compounds
GB0414093D0 (en) * 2004-06-23 2004-07-28 Glaxo Group Ltd Novel compounds
US7919581B2 (en) 2007-07-31 2011-04-05 Burnham Institute For Medical Research Bi-dentate compounds as kinase inhibitors
US20100038143A1 (en) * 2008-08-14 2010-02-18 George Alexander Burnett Drill cuttings treatment systems
JP2013509391A (ja) 2009-10-30 2013-03-14 グラクソ グループ リミテッド (3r,6r)−3−(2,3−ジヒドロ−1h−インデン−2−イル)−1−[(1r)−1−(2,6−ジメチル−3−ピリジニル)−2−(4−モルホリニル)−2−オキソエチル]−6−[(1s)−1−メチルプロピル]−2,5−ピペラジンジオンの新規結晶性形態
CN109305969B (zh) * 2017-07-27 2023-03-10 江苏恒瑞医药股份有限公司 哌嗪-2,5-二酮类衍生物、其制备方法及其在医药上的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130677D0 (en) * 2001-12-21 2002-02-06 Glaxo Group Ltd Medicaments and novel compounds
GB0414100D0 (en) * 2004-06-23 2004-07-28 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
GB0414092D0 (en) 2004-07-28
MA28698B1 (fr) 2007-06-01
TW200616635A (en) 2006-06-01
WO2006000400A1 (en) 2006-01-05
PE20060533A1 (es) 2006-09-03
US20070208031A1 (en) 2007-09-06
ZA200610121B (en) 2008-08-27
AR049651A1 (es) 2006-08-23
CA2571529A1 (en) 2006-01-05
EP1758893A1 (en) 2007-03-07
RU2007102272A (ru) 2008-07-27
CN1989130A (zh) 2007-06-27
IL179912A0 (en) 2007-05-15
BRPI0512359A (pt) 2008-03-04
MXPA06014544A (es) 2007-03-12
JP2008503535A (ja) 2008-02-07
AU2005256471A1 (en) 2006-01-05

Similar Documents

Publication Publication Date Title
NO20070157L (no) Substituerte diketopiperaziner som oksytocinantagonister
NO20070173L (no) Nye forbindelser
NO20062713L (no) 2,6 bisheteroaryl-4-aminopyrimidiner som adenosin reseptor antagonister
NO20060147L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
NO20064166L (no) Utvalgte CGRP-antagonister, deres fremstilling og deres anvendelse som medikanmenter
NO20052496L (no) Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og anvendelse derav som medikamenter.
NO20061839L (no) Benzimidazolderivater, sammensetninger inneholdende dem, fremstilling derav, og anvendelse derav
NO20055977L (no) Nye benzimidazolderivater
NO20044826L (no) Pyrrolidinderivater
NO20052493L (no) Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytiske sammensetninger.
NO20072515L (no) 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20060981L (no) Pyridazinderivater og deres anvendelse som terapeutiske midler
NO20052683L (no) Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20060146L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
NO20066055L (no) Pyridinderivater
NO20051695L (no) Nye spirokondenserte kinazolinoner og deres anvendelse som fosfodiestereaseinbibitorer
NO20090328L (no) Nye forbindelser 385
NO20062269L (no) Pyridin-karboksylsyrederivater som glucokinasemodulatorer
NO20050828L (no) lndol-3-svovelderivater
NO20092286L (no) Nitrogenhaldige heterosykliske forbindelser og anvendelse derav
NO20085087L (no) Nye heterocykliske forbindelser
MX2007010532A (es) Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii.
NO20064705L (no) Nye farmasoytiske preparater omfattende agonister av tyroidreseptoren
ATE476431T1 (de) Piperidin- und azetidinderivate als glyt1- inhibitoren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application